Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma

Marta Chesi, Peter Leif Bergsagel, Oluwatoyin O. Shonukan, Maria Luisa Martelli, Leslie A. Brents, Theresa Chen, Evelin Schröck, Thomas Ried, W. Michael Kuehl

Research output: Contribution to journalArticle

336 Citations (Scopus)

Abstract

Dysregulation of oncogenes by translocation to an IgH (14q32) or IgL (κ, 2p11 or λ, 22q11) locus is a frequent event in the pathogenesis of B- cell tumors. Translocations involving an IgH locus and a diverse but nonrandom array of chromosomal loci occur in most multiple myeloma (MM) tumors even though the translocations often are not detected by conventional cytogenetic analysis. In a continuing analysis of translocations in 21 MM lines, we show that the novel, karyotypically silent t(14;16)(q32.3;q23) translocation is present in 5 MM lines, with cloned breakpoints from 4 lines dispersed over an approximately 500-kb region centromeric to the c-maf proto- oncogene at 16q23. Another line has a t(16;22)(q23;q11), with the breakpoint telomeric to c-maf, so that the translocation breakpoints in these 6 lines bracket c-maf. Only these 6 lines overexpress c-maf mRNA. As predicted for dysregulation of c-maf by translocation, there is selective expression of one c-maf allele in 2 informative lines with translocations. This is the first human tumor in which the basic zipper c-maf transcription factor is shown to function as an oncogene. This is a US government work. There are no restrictions on its use.

Original languageEnglish (US)
Pages (from-to)4457-4463
Number of pages7
JournalBlood
Volume91
Issue number12
StatePublished - 1998
Externally publishedYes

Fingerprint

Proto-Oncogenes
Multiple Myeloma
Tumors
Oncogenes
Maf Transcription Factors
Neoplasms
Cytogenetic Analysis
Fasteners
B-Lymphocytes
Alleles
Cells
Messenger RNA

ASJC Scopus subject areas

  • Hematology

Cite this

Chesi, M., Bergsagel, P. L., Shonukan, O. O., Martelli, M. L., Brents, L. A., Chen, T., ... Kuehl, W. M. (1998). Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood, 91(12), 4457-4463.

Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. / Chesi, Marta; Bergsagel, Peter Leif; Shonukan, Oluwatoyin O.; Martelli, Maria Luisa; Brents, Leslie A.; Chen, Theresa; Schröck, Evelin; Ried, Thomas; Kuehl, W. Michael.

In: Blood, Vol. 91, No. 12, 1998, p. 4457-4463.

Research output: Contribution to journalArticle

Chesi, M, Bergsagel, PL, Shonukan, OO, Martelli, ML, Brents, LA, Chen, T, Schröck, E, Ried, T & Kuehl, WM 1998, 'Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma', Blood, vol. 91, no. 12, pp. 4457-4463.
Chesi, Marta ; Bergsagel, Peter Leif ; Shonukan, Oluwatoyin O. ; Martelli, Maria Luisa ; Brents, Leslie A. ; Chen, Theresa ; Schröck, Evelin ; Ried, Thomas ; Kuehl, W. Michael. / Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. In: Blood. 1998 ; Vol. 91, No. 12. pp. 4457-4463.
@article{0d080f1afe1643deb558ebc3dd23759e,
title = "Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma",
abstract = "Dysregulation of oncogenes by translocation to an IgH (14q32) or IgL (κ, 2p11 or λ, 22q11) locus is a frequent event in the pathogenesis of B- cell tumors. Translocations involving an IgH locus and a diverse but nonrandom array of chromosomal loci occur in most multiple myeloma (MM) tumors even though the translocations often are not detected by conventional cytogenetic analysis. In a continuing analysis of translocations in 21 MM lines, we show that the novel, karyotypically silent t(14;16)(q32.3;q23) translocation is present in 5 MM lines, with cloned breakpoints from 4 lines dispersed over an approximately 500-kb region centromeric to the c-maf proto- oncogene at 16q23. Another line has a t(16;22)(q23;q11), with the breakpoint telomeric to c-maf, so that the translocation breakpoints in these 6 lines bracket c-maf. Only these 6 lines overexpress c-maf mRNA. As predicted for dysregulation of c-maf by translocation, there is selective expression of one c-maf allele in 2 informative lines with translocations. This is the first human tumor in which the basic zipper c-maf transcription factor is shown to function as an oncogene. This is a US government work. There are no restrictions on its use.",
author = "Marta Chesi and Bergsagel, {Peter Leif} and Shonukan, {Oluwatoyin O.} and Martelli, {Maria Luisa} and Brents, {Leslie A.} and Theresa Chen and Evelin Schr{\"o}ck and Thomas Ried and Kuehl, {W. Michael}",
year = "1998",
language = "English (US)",
volume = "91",
pages = "4457--4463",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "12",

}

TY - JOUR

T1 - Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma

AU - Chesi, Marta

AU - Bergsagel, Peter Leif

AU - Shonukan, Oluwatoyin O.

AU - Martelli, Maria Luisa

AU - Brents, Leslie A.

AU - Chen, Theresa

AU - Schröck, Evelin

AU - Ried, Thomas

AU - Kuehl, W. Michael

PY - 1998

Y1 - 1998

N2 - Dysregulation of oncogenes by translocation to an IgH (14q32) or IgL (κ, 2p11 or λ, 22q11) locus is a frequent event in the pathogenesis of B- cell tumors. Translocations involving an IgH locus and a diverse but nonrandom array of chromosomal loci occur in most multiple myeloma (MM) tumors even though the translocations often are not detected by conventional cytogenetic analysis. In a continuing analysis of translocations in 21 MM lines, we show that the novel, karyotypically silent t(14;16)(q32.3;q23) translocation is present in 5 MM lines, with cloned breakpoints from 4 lines dispersed over an approximately 500-kb region centromeric to the c-maf proto- oncogene at 16q23. Another line has a t(16;22)(q23;q11), with the breakpoint telomeric to c-maf, so that the translocation breakpoints in these 6 lines bracket c-maf. Only these 6 lines overexpress c-maf mRNA. As predicted for dysregulation of c-maf by translocation, there is selective expression of one c-maf allele in 2 informative lines with translocations. This is the first human tumor in which the basic zipper c-maf transcription factor is shown to function as an oncogene. This is a US government work. There are no restrictions on its use.

AB - Dysregulation of oncogenes by translocation to an IgH (14q32) or IgL (κ, 2p11 or λ, 22q11) locus is a frequent event in the pathogenesis of B- cell tumors. Translocations involving an IgH locus and a diverse but nonrandom array of chromosomal loci occur in most multiple myeloma (MM) tumors even though the translocations often are not detected by conventional cytogenetic analysis. In a continuing analysis of translocations in 21 MM lines, we show that the novel, karyotypically silent t(14;16)(q32.3;q23) translocation is present in 5 MM lines, with cloned breakpoints from 4 lines dispersed over an approximately 500-kb region centromeric to the c-maf proto- oncogene at 16q23. Another line has a t(16;22)(q23;q11), with the breakpoint telomeric to c-maf, so that the translocation breakpoints in these 6 lines bracket c-maf. Only these 6 lines overexpress c-maf mRNA. As predicted for dysregulation of c-maf by translocation, there is selective expression of one c-maf allele in 2 informative lines with translocations. This is the first human tumor in which the basic zipper c-maf transcription factor is shown to function as an oncogene. This is a US government work. There are no restrictions on its use.

UR - http://www.scopus.com/inward/record.url?scp=0031839633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031839633&partnerID=8YFLogxK

M3 - Article

C2 - 9616139

AN - SCOPUS:0031839633

VL - 91

SP - 4457

EP - 4463

JO - Blood

JF - Blood

SN - 0006-4971

IS - 12

ER -